WAVE Life Sciences Ltd
NASDAQ:WVE
WAVE Life Sciences Ltd
NASDAQ:WVE
Price:
11.62
USD
-1.19%
Market Closed
Market Cap:
$2.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
SG |
|
P
|
Power Engineering Consulting JSC 2
VN:TV2
|
VN |
|
COSCO Shipping Energy Transportation Co Ltd
OTC:CSDXF
|
CN |
|
Sichuan New Energy Power Co Ltd
SZSE:000155
|
CN |
|
Sonaecom SGPS SA
LSE:0IZ2
|
PT |
Balance Sheet
Balance Sheet Decomposition
WAVE Life Sciences Ltd
WAVE Life Sciences Ltd
Balance Sheet Decomposition is not available for
WAVE Life Sciences Ltd
WAVE Life Sciences Ltd
Balance Sheet
WAVE Life Sciences Ltd
WAVE Life Sciences Ltd
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
161
|
150
|
143
|
175
|
147
|
185
|
151
|
89
|
200
|
302
|
602
|
|
| Cash Equivalents |
0
|
1
|
161
|
150
|
143
|
175
|
147
|
185
|
151
|
89
|
200
|
302
|
602
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
1
|
10
|
20
|
30
|
0
|
0
|
21
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
1
|
10
|
20
|
30
|
0
|
0
|
21
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
2
|
7
|
18
|
18
|
16
|
12
|
10
|
14
|
17
|
11
|
|
| Total Current Assets |
1
|
2
|
161
|
152
|
151
|
202
|
186
|
230
|
163
|
99
|
235
|
320
|
615
|
|
| PP&E Net |
1
|
1
|
3
|
9
|
27
|
40
|
55
|
45
|
41
|
44
|
36
|
28
|
20
|
|
| PP&E Gross |
1
|
1
|
3
|
9
|
0
|
40
|
55
|
45
|
41
|
44
|
36
|
28
|
20
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
3
|
0
|
10
|
17
|
25
|
32
|
38
|
43
|
46
|
50
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
50
|
30
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
4
|
4
|
4
|
14
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Total Assets |
2
N/A
|
3
+26%
|
165
+5 603%
|
165
0%
|
182
+10%
|
296
+63%
|
284
-4%
|
279
-2%
|
207
-26%
|
146
-29%
|
275
+88%
|
352
+28%
|
638
+81%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
0
|
0
|
3
|
5
|
8
|
13
|
9
|
14
|
7
|
17
|
13
|
16
|
16
|
|
| Accrued Liabilities |
0
|
0
|
1
|
4
|
9
|
13
|
19
|
16
|
20
|
23
|
24
|
29
|
35
|
|
| Short-Term Debt |
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
4
|
2
|
104
|
90
|
92
|
37
|
32
|
150
|
66
|
44
|
|
| Total Current Liabilities |
10
|
1
|
4
|
12
|
18
|
130
|
118
|
121
|
64
|
72
|
186
|
111
|
95
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
10
|
16
|
85
|
95
|
68
|
102
|
112
|
41
|
24
|
17
|
|
| Total Liabilities |
10
N/A
|
1
-91%
|
4
+356%
|
22
+439%
|
34
+56%
|
215
+524%
|
213
-1%
|
189
-11%
|
167
-12%
|
184
+10%
|
227
+24%
|
135
-41%
|
112
-17%
|
|
| Equity | ||||||||||||||
| Common Stock |
3
|
18
|
193
|
224
|
318
|
383
|
547
|
702
|
758
|
811
|
943
|
1 183
|
1 624
|
|
| Retained Earnings |
11
|
16
|
35
|
91
|
193
|
340
|
533
|
683
|
806
|
967
|
1 025
|
1 122
|
1 326
|
|
| Additional Paid In Capital |
0
|
0
|
3
|
10
|
22
|
38
|
57
|
72
|
88
|
119
|
129
|
156
|
228
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
8
N/A
|
2
N/A
|
161
+7 970%
|
143
-12%
|
148
+3%
|
81
-45%
|
72
-12%
|
91
+27%
|
40
-55%
|
37
N/A
|
48
N/A
|
217
+358%
|
526
+142%
|
|
| Total Liabilities & Equity |
2
N/A
|
3
+26%
|
165
+5 603%
|
165
0%
|
182
+10%
|
296
+63%
|
284
-4%
|
279
-2%
|
207
-26%
|
146
-29%
|
275
+88%
|
352
+28%
|
638
+81%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
21
|
21
|
22
|
24
|
28
|
30
|
34
|
49
|
60
|
87
|
119
|
153
|
188
|
|
| Preferred Shares Outstanding |
0
|
0
|
8
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
|
Switch to:
Switch to:
See Also
Discover More
